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NANOCOMPOSITES AND METHODS FOR
SYNTHESIS AND USE THEREOF
GRANT REFERENCE
The U.S. government has certain rights in this invention
pursuant to grant number NIDCR PO1 DE 11688.
FIELD OF THE INVENTION
The invention relates to nanocomposite compositions, as
well as methods of synthesis ofthe compositions. In particu-
lar, the invention relatesto liquid crystal-functionalized nano-
platelets, liquid crystal-templated nanoplatelets, nanocom-
posite compositions comprising said nanoplatelets, and
composite compositions comprising said nanocomposites.
BACKGROUND OF THE INVENTION
Thermosetting polymers have myriad uses in various
industries including aerospace and electronics industries as
well as in the manufacture of consumerproducts. In particu-
lar, thermosets have the properties ofbeing durable andrela-
tively resistant to environmental stressors such as heat, micro-
organisms, and water. As a result, thermosetting polymers
have found wide ranging uses as coatings; adhesives; con-
struction components such as for crack repair, bonding and
grouting; and in medical and dental applications such as in
bone cements and implants.
However, thermosetting polymers are often highly cross-
linked, adding to stability but increasing brittleness. Dental
polymers are prime examples of highly crosslinked, brittle
thermosets. Linear polymers can serve as highly effective
thermoplastic toughening agents in brittle thermosetting res-
ins (Hodgkin et al., Thermoplastic toughening of epoxy res-
ins: a critical review, Polymers for Advanced Technologies,
9:3-10, 1998). Unfortunately, the inclusion ofthermoplastics
into such polymers can reduce their elastic modulus at the
same time that they enhance ductility.
Similarly, it is often advantageousto include other compo-
nents in a thermosetting polymer which add desired charac-
teristics to a thermosetting polymer composition. For
example, a radiopaquefiller is often desirable in a composi-
tion including a thermosetting polymer. Radiopacity is useful
in numerous fields of use, such as in medical and dental
applications where radiography is often used to investigate
the status of implanted material. However, such fillers are
often incompatible with the polymer.Forinstance, zirconium
offers a significant source of radiopacity in dental composite
formulations of thermosetting polymers. Unfortunately, zir-
conium oxide particles and other metal containing particles
have proven difficult to disperse homogeneously into organic
resins.
Thus, there is a continuing need for improved polymer
composite and nanocomposite compositions, toughening
agents and methodsfor their synthesis.
SUMMARYOF THE INVENTION
A process for producing a layered organo-metal nanopar-
ticle is provided according to an embodimentofthe present
invention which includes providing a plurality of liquid crys-
tal monomers, providing a source of metal ions, placing the
plurality of liquid crystal monomersand the source of metal
ions in a reaction vessel under reaction conditions sufficient
to form a liquid crystal structure including the plurality of
liquid crystal monomers; and reacting the metal ions and the
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functional group of the plurality of liquid crystal monomers
to form a bond between the metal ions and the functional
group ofthe plurality of liquid crystal monomers yielding a
lamellar organo-metal nanoparticle. The liquid crystal mono-
mers each include an organic mesogen and a functional
group. The modified liquid crystal monomers each have a
long axis, the long axis having afirst terminus and a second
terminus. The functional group is bondedtothe first terminus.
In a preferred option, the source of metal ions includes a
metal selected from an alkaline earth metal, a transition metal
and a combination ofthese. Such transition metals are exem-
plified by hafnium, tantalum, tungsten, and a combination
thereof. In a further preferred embodiment, the source of
metal ions includeszirconium.For instance, a metal salt such
as ZrOCl, is a source of metal ions.
In a preferred embodiment, the nanoparticle includes a
layered zirconium phosphonate.
A functional group X formingpart ofa liquid crystal mono-
mer R—X is an oxygen-containing moiety in a particular
option, and the bond between the metal ions and the func-
tional group ofthe plurality of liquid crystal monomers is a
bond between the metal and an oxygen atom of the oxygen-
containing moiety. Illustrative functional groups include an
oxygen-containing moiety such as a phosphate, a phospho-
nate, a dimethyl sulfoxide complex ofa phosphate, a dimethyl
sulfoxide complex of a phosphonate, and a salt of any of
these. In one embodiment, a liquid crystal monomer is a
liquid crystal monomerphosphonate.
A liquid crystal monomeroptionally further includes one
or more moieties such as a bridging molecule, a miscibility
moiety, and a reactive group.
A nanoparticle included in one embodimentofan inventive
composition has an average particle size in the range of
1-1000 nanometers. In further embodiment, an inventive
nanoparticle has an averageparticle size in the range of5-500
nanometers. In a preferred embodiment, the nanoparticle is a
nanoplatelet. Such a nanoplatelet has a lateral dimension in
the range of 5-1000 nanometers and a thickness in the range
of 5-100 Angstroms
A nanoparticle composition is described which includes a
plurality of organic liquid-crystal monomers bound to a
lamellar metal-containing nanoparticle. A preferred lamellar
metal-containing nanoparticle includes a transition metal. A
further preferred metal-containing nanoparticle includeszir-
conium. In some embodiments, the metal containing nano-
particle includes an alkaline earth metal. Optionally, the plu-
rality of organic liquid crystal monomersincludesa plurality
ofthermotropic organic liquid crystal monomers. In a further
option, the plurality of organic liquid crystal monomers
includesa plurality of organic lyotropic liquid crystal mono-
mers.
A process for producing a layered organo-metal nanopar-
ticle according to the invention is detailed which includes
providing an exfoliated suspension of nanoparticles, the
nanoparticles each havinga first ion exchange group; provid-
ing a plurality of liquid crystal monomers, the liquid crystal
monomers each having an organic mesogen and a terminal
ion exchange group,the liquid crystal monomers each having
a long axis,the long axis havinga first terminus and a second
terminus, wherein the terminal ion exchange group is bonded
to the first terminus. Further described is mixing the nanopar-
ticle suspension and the plurality of modified liquid crystal
monomers to create a reaction mixture and exposing the
reaction mixture to ion exchange reaction conditions such
that ion exchange occurs betweenthefirst ion exchange group
of the nanoparticles and the terminal ion exchange group of
the liquid crystal monomers, creating bonds between the
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nanoparticles and the liquid crystal monomers, yielding a
lamellar liquid crystal-functionalized nanoparticle.
In a preferred option, first ion exchange group and the
terminal ion exchange group are each independently selected
from the group consisting of: a phosphate, a phosphonate, a
halophosphate, a halophosphonate, a dimethylsulfoxide
complex of a phosphate, a dimethylsulfoxide complex of a
phosphonate, anda salt of any ofthese.
In a further preferred option, the nanoparticle suspension
includes a zirconium phosphonate. Another preferred option
according to the invention is described in which the nano-
platelet suspension includes y-ZrPO,,(O,P(OH),).
Ananocomposite composition is provided invention which
includes a thermoplastic material and a layered organo-metal
nanoparticle according to an embodiment of the invention.
Additionally, a curable composition is provided which
includes a thermosetting material and a nanocomposite
including a thermoplastic material and a layered organo-
metal nanoparticle. Optionally, the ratio of thermosetting
material to toughening agent is in the range of 10:0.01-1:1,
inclusive. Further optionally, the ratio ofthermosetting mate-
rial to toughening agentis in the range of 10:0.1-1:0.5, inclu-
sive.
A polymer composite composition according to an
embodimentof the invention is described which includes an
interpenetrating network having a thermosetting polymer
component and a toughening agent component wherein the
toughening agent componentincludes a nanocomposite hav-
ing a thermoplastic material componentanda layered organo-
metal nanoparticle component.
DETAILED DESCRIPTION OF THE INVENTION
Layered organo-metal particles are provided according to
the present invention as well as methodsfor their production.
Such particles have various uses, for instance asfillers in
polymer compositions.
In a particular embodiment, inventive particles are a com-
ponentof a polymer nanocomposite formulated as a tough-
ening agent. An inventive toughening agent includes a lay-
ered organo-metal particle and a thermoplastic polymer.
An inventive composite polymer composition is provided
which includes a toughening agent and a thermosetting poly-
mer. Desirable characteristics of a composite polymer are
enhancedin a composition of the invention, such as increas-
ing ductility, increasing elastic modulus andplastic strain
hardening. In addition, an inventive toughening agent pro-
vides radiopacity, while remaining translucentor transparent,
thereby facilitating light activated processes such as photo-
polymerization, photocuring and/or photoinitiation. Advan-
tageously, in one formulation, an inventive toughening agent
confers radiopacity to an inventive composite withoutinter-
fering with the translucency or transparency of such a com-
posite composition.
A layered organo-metal particle according to an embodi-
ment of the invention may be a lamellar liquid crystal-tem-
plated nanoparticle or a lamellar liquid crystal-functionalized
nanoparticle. Each of these types of layered organo-metal
particle may include a lamellar organic liquid crystal struc-
ture bonded to one or more nanoparticles.
Nanoparticles which form part of a layered organo-metal
particle incorporate metal ions or atoms. Preferred specific
metals include an alkaline earth metal and/or a transition
metal. An exemplary alkaline earth metal is barium. Exem-
plary transition metals are hafnium, tantalum and tungsten. A
particularly preferred metal for radio-opacity is zirconium.
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Further preferred are nanoparticles including a lamellar zir-
conium phosphate and/or a zircontum phosphonate.
Nanoparticles included in inventive compositions prefer-
ably have a mean particle size in the range of 1-1000 nanom-
eters. Further preferred are nanoparticles having a mean par-
ticle size in the range of 0.5-500 nanometers. Nanoparticles
are preferably in the form ofplatelets. Such platelets typically
have a lateral dimension in the range of 5-1000 nanometers,
preferably in the range of 10-100 nanometers and a thickness
in the range of 5-100 angstroms, preferably in the range of
5-50 angstroms.
A lamellar liquid crystal structure included in an inventive
layered organo-metal particle is formed from organic liquid
crystal monomers.In a particular embodiment,a liquid crys-
tal monomer has a chemical structure represented by the
symbol “R” where Ris preferably a molecule having a long
axis and whichincludes a calamitic mesogen,a first terminus
at one end ofthe long axis and a second terminus at a second
end ofthe long axis. A calamitic mesogen includedin aliquid
crystal monomer may be an amphiphilic or nonamphiphilic
mesogen and thus suitable liquid crystal monomers may be
lyotropic and/or thermotropic liquid crystal monomers,
which are known synonomouslyas liquid crystal precursors.
Such calamitic mesogens are knownin the art and any of the
various knownorganic calamitic mesogens maybe used in a
composition according to the invention.
It is appreciated that a combination of two or more
mesogensis optionally included in a liquid crystal monomer.
For use in a process of forming a lamellar organo-metal
nanoparticle, a liquid crystal monomerR includes a moiety X
bondedto a terminusto form a liquid crystal monomerhaving
the formula R—X. The symbol X in this formula is either: 1)
a functional group for reaction with a metal containing com-
pound to form a bond between the functional group and the
metal in a method of producing a liquid crystal-templated
nanoparticle, or 2) X is an ion exchange group for ion
exchange reaction with a second ion exchange group in a
method for producing a liquid crystal-functionalized nano-
particle, the second ion exchange group bondedto a metal in
a metal-containing nanoparticle.
The moiety X is preferably an oxygen-containing moiety
such as a polyoxyphosphorus moiety,illustratively including
a phosphate group, a phosphonate group, dimethylsulfoxide
complexes thereof, or a salt of any ofthese.
Preferably, a liquid crystal monomer R—X_ further
includes one or more moieties for enhancing desirable prop-
erties of a monomerfor use in inventive compositions and
methods. Such moieties illustratively include: a miscibility
group selected to enhance miscibility ofthe monomers with a
thermoplastic material and/or a thermosetting material
included in an inventive nanocomposite and/or composite
composition; a bridging moiety selected to increase the long
axis ofamonomer; anda reactive group selected to react with
a thermoplastic material and/or a thermosetting material
included in an inventive composition.
Enhancement ofmiscibility may be usedto increase homo-
geneity of a curable composite composition. For example,
physical interaction of a host polymer and a liquid crystal
monomerportion of a layered organo-metal particle in a
toughening agent composition and/or composite composition
of the invention enhances miscibility of the polymer and
particle. Such physical interaction includes, for instance,
dipole/dipole interactions.
In particular, introduction of functional groups in a liquid
crystal monomer may allow for such interaction with a ther-
moplastic material. For example, where a thermoplastic
material includespolar ester functions, such as are present in
US 7,556,743 B2
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polycaprolactone, introduction of ether or ester groups to a
liquid crystal monomer aids in miscibility. The identity of
such a miscibility group selected to enhance miscibility ofthe
monomerswith another componentofan inventive composi-
tion will depend on the identity ofthe other componentsofthe
composition. Inclusion of a miscibility group for enhancing
miscibility is known in the art and selection of a suitable
group may be madeby oneofordinary skill in the art without
undue experimentation.
A miscibility group present in a liquid crystal monomer
R—is bondedto one or more atomsofthe long axis of the
monomersuch that the miscibility group forms part of the
long axis or is pendant therefrom. In one embodiment, a
miscibility group is present at a second terminus ofthe mono-
mer. In other preferred embodiments,a miscibility group may
be located elsewhere, for instance, between a mesogen and
the moiety X.
In a further option, a liquid crystal monomer R—X
includes one or more bridging moieties, for instance in order
to extend the linear dimension ofthe monomer. Such a bridg-
ing moiety is preferably a C,-C,, moiety, preferably straight
chain, but optionally branched, alkyl moiety which may be
substituted or unsubstituted, saturated or unsaturated.
Optionally, a non-carbon atom maybe included in the C,-C,,,
backbone,illustratively including an oxygen, nitrogen, sul-
fur, and phosphorus. A bridging molecule optionally includes
one or more pendant moieties pendant from the C,-C,, back-
bone. A pendant moiety may be included to enhance misci-
bility ofan inventive nanoparticle with a thermoplastic and/or
thermosetting material in one embodiment. Such a pendant
moiety may be the same as a miscibility group or different. In
a further embodiment, a reactive pendant moiety may be
included which is polymerizable and/or cross-linkable to
form a bond to a thermoplastic material and/or thermosetting
material for instance.
A bridging moiety is bonded to one or more atoms of the
long axis ofthe monomersuchthat the bridging moiety forms
part of the long axis in a preferred embodiment. A bridging
moiety may belocated for instance, between a mesogen and
the moiety X, between a mesogen and a miscibility group,
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between a terminal reactive group and mesogen, between a
miscibility group and a mesogen,and/orother position within
the liquid crystal monomer.
In a further option, a reactive groupis present as part ofthe
liquid crystal monomer,preferably at a terminus, for reaction
with a reactive group present on a thermoplastic or thermo-
setting material, further described below. Suitable reactive
groups include nucleophiles and groups comprising at least
one electron deficient alkene. Suitable nucleophiles include
ester groups, organic acid groups, amine groups, hydroxyl
groups, and sulfhydryl groups. More preferred reactive
groups comprise electron deficient alkenes. Preferred elec-
tron deficient alkenes independently are selected from the
group consisting of substituted and unsubstituted alkenyl
ester groups comprising a polymerizable unsaturated carbon-
carbon bond, wherein said alkenyl group has from about 2 to
about 12 carbon atoms. Preferred alkenyl esters are acryloyl
groups and methacryloyl groups, said substituted alkenyl
ester groups comprising at least one halogen atom selected
from the group consisting of chorine atoms, bromine atoms,
and iodine atoms. Optionally, a reactive group is pendant
from the long axis of the liquid crystal monomer.
In a preferred embodiment of a process of producing a
lamellar liquid crystal-templated nanoparticle, liquid crystal
monomersare includedto achieve a mobile lamellar ordering
in organic solution withoutcrystallizing. In order to achieve
this mobile lamellar ordering in organic solution, a mixture of
two or moreliquid crystal monomers R—X maybe used in
one embodiment. For example, two or more liquid crystal
monomers having differing structure may be included in
order to suppress crystallization.
Liquid crystal monomers are synthesized using any suit-
able method. A preferred methodfor synthesizing one type of
liquid crystal monomersuitable for use in the present inven-
tion is described in U.S. patent application Ser. No. 10/190,
470.
Diagram 1 depicts an exemplary liquid crystal monomer
R—Xto illustrate a described liquid crystal monomer and
embodiments of inventive processes incorporating such
monomers to produce a layered organo-metal nanoparticle
according to the invention.
1)
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(2)R R RR R RR
| NH; | ZrOChyoFOH — >O=P—ON —_> [a-Zr(PO3-)o],
OH ONH4 RR R RR
(3)i R R RRR
yn + |[y-Zr(PO4)(O2P(OH)2]n ~—> [y-Zr(PO4)(O2P(OH)-)]2
O
An exemplary liquid crystal monomer R—X is shown at
(1) in Diagram 1. The exemplary monomer R—Xis shownin
two schematic examples ofinventive processes for producing
a layered organo-metal nanoparticle. Shownat (2) is a sche-
matic exampleofa liquid crystal templating process for pro-
ducing a layered organo-metal nanoparticle. Shownat (3) is a
schematic example ofan ion exchangeprocess for producing
a layered organo-metal nanoparticle.
Processes for Producing a Lamellar Liquid Crystal-Tem-
plated Nanoparticle
Processes are provided according to the present invention
for production ofa lamellar liquid crystal-templated nanopar-
ticle. In particular, an inventive method for production of a
lamellar liquid crystal-templated nanoparticle includes pro-
viding a plurality of liquid crystal monomers R—X having a
terminal functional group X, the terminal functional group X
capable of reaction with a metal containing compound to
form a bond between the functional group X and the metal.
The liquid crystal monomersare placed in a reaction vessel,
optionally with a solvent, at concentrations and under condi-
tions sufficient to produce a liquid crystal structure. Condi-
tions for producing a liquid crystal structure from liquid crys-
tal monomersin solution are knowninthe art and depend on
solution concentration, temperature, and composition.
In one example offorming a liquid crystal structure, liquid-
crystal-forming ammonium phosphonate monomers (con-
taining approximately 5 wt. % of water) are dissolved
together in a solution oftoluene (approximately 50 wt. %) at
60° C. to form a lyotropic liquid crystal phase, i.e. a phase
which spontaneously organizes as a lamellar liquid crystal
structure based on solution concentration, temperature, and
composition.
A metal ion source is brought into contact with the liquid
crystal structure under reaction conditions which allow bond-
ing between a metal and the terminal functional groups
present on the lamellar liquid crystal structureto yield aliquid
crystal-templated nanoparticle in which a lamellar liquid
crystal structure is bonded to one or more nanoparticles.
A metal ion source reacted with a liquid crystal monomer
R—Xhaving a terminal functional group X includes a metal
salt, preferably an alkaline earth metal and/or a transition
metal salt capable of reaction with a terminal functional
group on a lamellar liquid crystal structure to form a bond
between a metal atom in the metal salt and the terminal
functional group. A metal salt used as a source of metal ions
may be an inorganic salt or an organicsalt. A preferred inor-
ganic metal salt includes an oxyanion, such as an oxychlo-
ride, oxynitrate, or phosphate. Further exemplary metalsalts
useful in synthesis of a liquid crystal-templated nanoparticle
include alkaline earth metal and transition metal sulfates,
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nitrates, chlorides, and acetates. Exemplary organic salts
include carboxylates, carbonates, diketonates and alkoxides.
In a particularly preferred embodiment, a liquid crystal-
templated nanoparticle composition is produced in a single
step process. For example, a single phase mixture is generated
including a liquid crystal monomer having a terminal func-
tional group. The single phase mixture may further include an
amount of water in the range of about 1-20 weight percent
relative to the weight of the monomers. Also preferably
included in the single phase mixture is an organic solvent. The
organic solventis typically included in an amountinthe range
of about 30-80 weight percent relative to the monomer/water
components. The single phase mixture is then brought into
contact with the metal ion source, i.e. an aqueous or organic
solution of metal complexes. These components are prefer-
ably reacted in a single step to form a liquid crystal-templated
nanoparticle.
Thus, the single phase mixture is mixed with a solution
containing the metal ion source to form a two phase mixture.
The metal complex diffuses into the liquid crystalline single-
phase mixture and reacts with it. This is a two phasereaction,
with metal complexes diffusing into the liquid-crystal-form-
ing system and byproducts diffusing out of it. The original
solution ofmetal complexesis therefore not required to com-
bine in a single phase with the nanoplatelet forming phase.
The two phase mixture hasa ratio ofmetalionsto the liquid
crystal forming monomersofat least about 1:2. However, in
practice, an excess of metal species is included in order to
ensure that the reaction proceeds to completion. Mechanical
mixing is employed to increase the contact area within the
twophasereaction.
In a particular example of such a single step process, a
quantity of liquid crystal monomers having terminal phos-
phonate groupsare placed in a toluene solution and mixed
with a saturated aqueous solution of zirconyl chloride
(ZrOCI,) causing immediate precipitation of zirconium con-
taining nanoplatelets bound to a liquid crystal structure
through the phosphonate groups, thus producing an inventive
lamellar liquid crystal-templated nanoplatelet composition.
In general, phosphonate moieties cannot be reacted with
metal ions, such as zirconium ions, to give a lamellar structure
suitable for exfoliation. Rather, the reaction ofa phosphonate,
typically a phosphonic acid, and metal ions, such as zirco-
nium ions produced from ZrOCl,, will give an amorphous
materialthatis oflittle value as a dental material or in other
applications where layered crystalline structure is desirable.
(P.-A. Jaffrées, V. Caignaert, and D. Villemin, “A direct access
to layered zirconium-phosphonate materials from dialky-
Iphosphonates,” Chemical Communications, pp. 1997-1998
1999.) In particular, a layered crystalline structure is advan-
tageous in applications in which radiopacity is desirable
US 7,556,743 B2
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simultaneous with transparencyor translucency of the mate-
rial to other formsof radiation, such as light. Surprisingly, it
is found that a process ofthe present invention allows forma-
tion of highly ordered liquid crystal-templated nanoparticle
structures. In particular, this application discloses liquid crys-
tal structures that are “lamellar,” i.e. structured with a 2-di-
mensional layered ordering. Ordered in a lamellar fashion,
the liquid crystal monomersare linked together, or “bridged,”
by metal cations bound to more than one liquid crystal mono-
mer, resulting in a layered metal phosphonate structure, that
is, a lamellar liquid crystal-templated nanoparticle.
In a preferred embodimenta structure including lamellar
Zr(PO,R),, is produced in situ in an advantageous morphol-
ogy by forming a lamellar liquid crystal phase of a liquid
crystal monomerphosphonate in a suitable organic solvent,
such as toluene. The polar phosphonate head groups are
reacted within the interlamellar phosphonate domains with a
concentrated source of metal cations, such as a saturated
aqueous ZrOC1,solution, to form the metal phosphonate and
thus Zr(PO;R),, an exemplary layered organo-metal nano-
particle. Byproducts such as water and ammonium salts may
be removed by vacuum, for example.
Processes for Producing a Lamellar Liquid Crystal-Function-
alized Nanoparticle
In another embodimentofan inventive process for produc-
ing a lamellar organo-metal nanoparticle a liquid crystal
monomer is bound to a nanoparticle by ion exchange to
producea liquid crystal-functionalized nanoparticle. In such
an embodiment, a nanoparticle is provided for use in an ion
exchangereaction to produce a liquid crystal-functionalized
nanoparticle. A provided nanoparticle includes a metal bound
to an ion exchange group. The ion exchange group is prefer-
ably an oxygen-containing moiety such as a polyoxyphos-
phorus moiety, illustratively including a phosphate group, a
phosphonate group, a dimethylsulfoxide complexes thereof,
or a salt of any of these.
Nanoparticles which form part of a layered organo-metal
particle are metal containing particles. In particular, preferred
metals included in the particles are an alkaline earth metal
and/or a transition metal. An exemplary alkaline earth metal
is barium. Exemplary transition metals include hafnium,tan-
talum and tungsten.A particularly preferred metal includedin
a metal containing nanoparticle is zirconium.
Nanoparticles included in inventive compositions prefer-
ably have a meanparticle size in the range of 1-1000 nanom-
eters. Further preferred are nanoparticles having a mean par-
ticle size in the range of5-500 nanometers. Nanoparticles are
preferably in the form ofplatelets. Such platelets typically
have a lateral dimension in the range of 5-1000 nanometers,
preferably in the range of 10-100 nanometers and a thickness
in the range of 5-100 angstroms, preferably in the range of
5-50 angstroms.
Highly preferred nanoparticles including metals having an
ion exchange group are selected from the group consisting of
y-zirconium phosphate phosphonates and other layered zir-
conium phosphonates, such as a-zirconium phosphonate.
Suitable zirconium phosphonates maybe prepared using the
procedure described in G. Alberti et al., Inorg. Chem., 36,
2844 (1997), incorporated herein by reference. Zr(PO,)F
(OSMe,) may be prepared using the procedure described in
“Synthesis and crystal structure of a new layered zirconium
phosphate compound, Zr(PO,,)F(OSMe,), D. M. Poojary, B.
Zhang and A.Clearfield, J. Chem. Soc., Dalton Trans., 2453
(1994).
In an embodiment of an inventive process, binding of a
liquid crystal monomerto a nanoparticle is accomplished by
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ion exchange. For example, a liquid crystal-functionalized
nanoplatelet is produced by forming a reaction mixture com-
prising a nanoplatelet having a first ion exchange group X',
and a liquid crystal monomer R—X, X being a second ion
exchange group, wherein the first and second ion exchange
groups are ion exchanged to produce a liquid crystal mono-
mer boundto a nanoparticle.
A provided nanoparticle having a first ion exchangeable
group is preferably provided as an exfoliated nanoplatelet
suspension, particularly, a nanoplatelet colloid. Such a sus-
pension is mixed with a liquid crystal monomerhaving an ion
exchangeable terminal group to create a reaction mixture.
The reaction mixture is exposed to ion exchange reaction
conditions effective to induce ion exchange betweenthefirst
functional groups and the second functional groups.
A provided exfoliated suspension is produced, for
instance, by adding an exfoliating solvent to a metal com-
pound having an ion exchangeable group to produce a nano-
platelet colloidal suspension. The process of exfoliation
involves the creation of nanoplatelets and their separation of
layered, or “pillared,” into isolated suspension. The suspen-
sion is considered “colloidal” because these individually iso-
lated nanoplatelets are of a colloidal size, that is, having a
mean particle size in the range of 1-1000 nanometers. The
original layered crystals are typically not colloidal in size
prior to exfoliation. Generally, a suitable exfoliating solvent
is a polar solvent, illustratively including water; a ketone,
such as acetone, methyl] ethyl ketone, and diethyl ketone; an
amide such as formamide, and dimethylformamide; dioxane,
dimethyl sulfone, dimethyl sulfoxide, dibutyl oxide; and a
combination ofany ofthese. Exemplary preferred exfoliating
solvents are aqueoussolutions ofketones, such as acetone. A
preferred exfoliating solvent is aqueous acetone including
about 40-90 volume % acetonein water, preferably about 80
volume % acetone in water. Further details of producing an
exfoliated suspension may be foundin G.Alberti et al., Inorg.
Chem., 36, 2844 (1997).
A preferred exfoliated suspension nanoparticle material
includes y-ZrPO,(O,P(OH)),).
An exemplary scheme for synthesis of a liquid crystal
functionalized nanoplatelet is shown in Diagram 1. In par-
ticular, Diagram 1 shows an exemplary scheme(3) in which
y-ZrPO,(O,P(OH),), is functionalized with a liquid crystal
monomerbysubstituting O,P(OH),— with an organic phos-
phonate, RO,POH—, where Ris a liquid crystal monomer,
by an ion-exchangereaction.
In an example of an ion exchange reaction, Diagram 1
shows an exemplary liquid crystal monomer R—X having a
terminal functional group X which is an organophosphate
group. The organophosphate on the liquid crystal monomer
R—Xis hydrolyzedto a phosphonic acid group. The organic
phosphonate is hydrolyzed to phosphonic acid by addition of
adealkylating agent, followedby water. Suitable dealkylating
agents include,but are notlimited to, trimethyl silyl bromide.
Following dealkylation, the resulting silyl phosphoester is
hydrolyzed to yield a liquid crystal monomerhaving a termi-
nal phosphonic acid group.
In one example of a process for producing an inventive
layered organo-metal nanoparticle, an exfoliating mixture
including zirconium phosphonate groups is mixed with the
liquid crystal monomerhaving a terminal phosphonic acid
group to produce a mixture whichis subjected to conditions
effective to induce a topotactic phosphoric-phosphonate
replacement reaction. In a particular embodiment, reaction
conditions include reaction in an aqueous organic medium.
An example of a preferred aqueous organic medium includes
a medium of 30-90% acetone in water. Typically reaction
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temperature is elevated over room temperature, in the range
of about 30-100° C., for instance, preferably in the range of
about 60-95° C. Typical reaction times are in the range of
about 1 minute to several days. The phosphonic acid groups
on the liquid crystal are ion-exchanged with the activated
zirconium phosphonate groups, producing a reaction product
including liquid crystal-functionalized nanoplatelets having
the liquid crystal bonded to the zirconium via the phospho-
nate.
Nanocomposite Compositions
A toughening agent nanocomposite composition is pro-
vided according to the invention which includes a thermo-
plastic polymer andan inventive layered organo-metal nano-
particle. An inventive toughening composition may include
an inventive layered organo-metal nanoparticle in the form of
a lamellar liquid crystal templated nanoparticle and/or a
lamellar liquid crystal-functionalized nanoparticle.
A thermoplastic polymer included in an inventive compo-
sition is a polymer which softens when heated and hardens
again when cooled. A thermoplastic polymer included in an
inventive composition may be any of various thermoplastic
polymers, illustratively including polystyrenes; polyolefins
such as polyethylenes and polypropylenes; acrylics; polyes-
ters, such as polycaprolactones; fluoroplastics; polyacetals;
polyacrylonitriles; polyamides; polyamide-imides; pol-
yaryletherketones; polybutadienes; polybutylene; polycar-
bonates; polyphthalamides; polysulfones; polyvinylchlo-
rides; polyvinylidene chlorides; and combinations thereof. A
thermoplastic polymer maybeprovided as a polymerand/or
in an oligomeric or monomeric polymerizable form for later
polymerization. A thermoplastic polymer and an oligomer
and monomerpolymerizable to make a thermoplastic poly-
merare referred to herein as a thermoplastic material.
In a preferred embodiment, a thermoplastic material is a
liquid crystal monomer R including one or more reactive
groups for polymerization of the thermoplastic material.
In one embodiment, a liquid crystal monomerincluded as
a thermoplastic material in an inventive composition is a
linear monomer and/or oligomer polymerizable via reaction
of reactive groups to form a linear polymer. Such a linear
liquid crystal monomer may be a difunctional monomer,
including afirst reactive group R, at a first terminus and a
second reactive group R, at a second terminus. The reactive
groups at the first and second termini may be the same or
different. In one embodiment, the reactive groups atthe first
and second termini are different, in order to provide asym-
metry in the polymer which suppresses crystallinity while
maintaining a nematic state.
Suitable reactive groups include nucleophiles and groups
comprising at least one electron deficient alkene. Suitable
nucleophiles includeester groups, organic acid groups, amine
groups, hydroxyl groups, and sulfhydryl groups. More pre-
ferred reactive groups comprise electron deficient alkenes.
Preferred electron deficient alkenes independently are
selected from the group consisting of substituted and unsub-
stituted alkenyl ester groups comprising a polymerizable
unsaturated carbon-carbon bond, wherein said alkenyl group
has from about 2 to about 12 carbon atoms. Preferred alkenyl
esters are acryloyl groups and methacryloy] groups, said sub-
stituted alkenyl ester groups comprising at least one halogen
atom selected from the group consisting of chorine atoms,
bromine atoms, and iodine atoms.
A liquid crystal monomerRmayfurther include a bridging
moiety and/or miscibility group as described above.
In a preferred option, a liquid crystal monomer R is
includedin a thermoplastic material whichis part ofan inven-
10
15
20
25
30
35
40
45
50
55
60
65
12
tive toughening agent. In a further preferred option, a liquid
crystal monomerR includedin a toughening agentas a ther-
moplastic material is the same liquid crystal monomer R as
used to make a layered organo-metal nanoparticle included in
the toughening composition, although the terminal group X is
optionally omitted in this context.
Preferably, the liquid crystal monomers included in an
inventive toughening agent exhibit very little or no polymer-
ization shrinkage.In a preferred embodiment,the liquid crys-
tal monomersexhibit polymerization shrinkage ofabout3 vol
% change or less, most preferably 2 vol % changeorless.
Examples of such suitable low- or zero-polymerization
shrinkage liquid crystal monomers include elongated
mesogens, randomly substituted mesogens, mesogenic
dimers, and the like, described in U.S. Pat. No. 6,258,974, and
co-pending U.S. patent application Ser. No. 10/057,548, U.S.
patent application Ser. No. 10/057,506, U.S. patent applica-
tion Ser. No. 10/056,121, and US.patent application Ser. No.
10/190,470.
Liquid crystal monomers are synthesized using any suit-
able method. A preferred methodfor synthesizing one type of
liquid crystal suitable for use in the present invention is
described in U.S. patent application Ser. No. 10/190,470.
In a preferred process of producing a nanocomposite, an
inventive layered organo-metal nanoparticle is formed in the
presence ofa thermoplastic material. In an alternative option,
a layered organo-metal nanoparticle may be formed and then
mixed with a thermoplastic material to form an inventive
nanocomposite.
Thus, in one process for producing an inventive toughening
agent, a thermoplastic material is mixed with liquid crystal
monomers and a metalsalt to produce a reaction mixture. The
reaction mixture is incubated to produce a lamellar liquid
crystal-templated nanoparticle having a thermoplastic mate-
rial occupying the interlamellar spaces (also knownas “gal-
leries”’) between the ordered monomers. Thus, in such a pro-
cess, nanoplatelets are grownin situ within the desired ductile
(“thermoplastic”) matrix, termed thermoplastic material
herein. In such a configuration nanoplatelets, already contain-
ing polymer within the galleries, have no need of further
exfoliation. They are already “intercalated” by the thermo-
plastic material creating a new hybrid organic-inorganic ther-
moplastic nanocomposite.
In one example of in situ formation of an inventive tough-
ening agent, a metal ion source anda plurality ofliquid crystal
monomersare provided, along with a thermoplastic material.
Ina preferred embodiment, the thermoplastic material is pro-
vided in a liquid or semi-liquid state or heated to render the
thermoplastic material liquid or semi-liquid, such that the
material may be mixed with other components. The liquid
crystal monomers, thermoplastic material, and metal ion
source are mixed, yielding a nanocomposite which is a mis-
cible mixture of a liquid crystal-templated nanoparticle and
thermoplastic material.
In a further specific example, liquid-crystal-forming
ammonium phosphonate monomers, containing approxi-
mately 5 wt. % water, are dissolved togetherin a solution of
toluene (approximately 50 wt. %) at 60° C. to form a liquid
crystal phase, i.e. a phase which spontaneously organizes as a
lamellar liquid crystal structure based on solution concentra-
tion, temperature, and composition. In a particular example of
such a single step process, a quantity of liquid crystal mono-
mers R—X, where X is a terminal phosphonate group, are
placed in a toluene solution and mixed with a saturated aque-
ous solution ofzirconyl chloride (ZrOC1,) causing immediate
precipitation of zirconium containing nanoplatelets bound to
a liquid crystal through the phosphonate group, thus produc-
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ing an inventive lamellar liquid crystal-templated nanoplate-
let. A thermoplastic material, such as flowable polycaprolac-
tone may be added to the lamellar liquid crystal-templated
nanoplatelet to produce an inventive toughening agent.
In one embodiment, a thermoplastic material itself acts as
an organic solvent for the liquid crystal monomers. Thus, for
example, a thermoplastic material is provided as a polymer
melt, such as flowable polycaprolactone. A composition
including liquid-crystal-forming ammonium phosphonate
monomers and approximately 15 wt. % water is added. If
desired, the thermoplastic material may be plasticized with a
small amount of solvent, such as toluene, to reduce the vis-
cosity of a lamellar phase of the material. A precipitation
reaction with saturated aqueous zirconyl chloride is carried
out in the presence ofthe molten polymerwhile the tempera-
ture is maintained above the melt point of the thermoplastic
material. As the nanoplatelets precipitate, they are incorpo-
rated directly into the polymer melt, resulting in an optically
translucent organic/inorganic hybrid thermoplastic nano-
composite. Such a nanocomposite may be used in various
waysincluding as a material for formingarticles ofmanufac-
ture and as a material for use in conjunction with another
polymer. For instance, an inventive nanocomposite may be
formulated as a “toughening agent” in a composite composi-
tion with a thermosetting polymerin order to provide desir-
able properties to the composite.
Where the thermoplastic material is a monomeroroligo-
mer polymerizable to make a thermoplastic polymer, the
thermoplastic material may be polymerized at the time of
liquid crystal-templated nanoparticle formation orlater.
As noted above, a lamellar liquid crystal templated nano-
particle may be formedin situ in the presenceofliquid crystal
monomersfor forming a thermoplastic matrix. Optionally in
such an embodiment, a liquid crystal monomer portion R
which formspart of a lamellar liquid crystal templated nano-
particle includes a reactive group suchthat the lamellar liquid
crystal templated nanoparticle may be reacted to form a bond
to one or more molecules of the thermoplastic material. For
example, a zirconium phosphonate nanoparticle bonded to a
liquid crystal which includes a polymerizable group in the
form of a terminal alkene is formed in the presence of a
polymerizable thermoplastic material having reactive groups
for polymerization, such as a dialkene thermoplastic mono-
mer. By sucha method a ceramic reinforcing phase is formed
directly in the nanocomposite in a dispersed form. Subse-
quent polymerization of the phosphonate alkene functional
reactive terminal groups into the crosslinking difunctional
thermoplastic monomer may then be performed. The func-
tional alkene groups assure that the zirconium phosphonate
forms a separate, ductile continuous phase interdispersed
with the dialkene monomer which will lead to mechanical
reinforcement of the composite.
In one embodiment, a thermoplastic material includes a
photopolymerizable liquid crystal monomer.
Asnoted above, in a preferred embodiment, a liquid crystal
monomerpreferably includes one or more functional groups
for increasing miscibility of the liquid crystal functionalized
platelet with a thermoplastic polymer. Thus an inventive liq-
uid crystal-functionalized nanoplatelet is at least partially
soluble in a thermoplastic polymerincluded in a toughening
agent.
A curable composition is provided according to the inven-
tion which includes an inventive nanocomposite toughening
agent and a thermosetting polymer. In a preferred embodi-
ment, the toughening agent and the thermosetting polymer
form an interpenetrating network in a cured form ofthe cur-
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able composition. Such a material may be used in any of a
variety of applications, such as a dental material, and/or in
articles of manufacture.
In one embodiment, a curable composition includes com-
ponents for formation of a liquid crystal-templated nanopar-
ticle, a thermoplastic material, and a thermosetting monomer
such that a liquid crystal-templated nanoparticle is produced
in the presence of constituents included in a curable compo-
sition.
Thus, for example, a plurality of liquid crystal monomers
and a metal containing compoundare provided along with
thermosetting monomers, and thermoplastic material. Pref-
erably, where the thermoplastic material is a thermoplastic
polymer, it is provided in a liquid or semi-liquid state or
heated to render the polymerliquid or semi-liquid, such that
the polymer may be mixed with other components. The liquid
crystal monomers, thermosetting monomers, thermoplastic
material, and metal containing compoundare mixed,yielding
a curable composite which is a miscible mixture of a liquid
crystal-templated nanoparticle, thermosetting monomers,
and thermoplastic material.
In a preferred embodiment, the liquid crystal-templated
nanoparticle, a thermoplastic material, and a thermosetting
monomerare miscible such that the curable composition is a
single phase composition. Thus, for instance, the thermoset-
ting monomerpreferably acts as a solvent and softener to
mobilize the toughening agent, thereby making the entire
mixture fluid. As the thermosetting monomer polymerizes, it
simultaneously formsa brittle thermoset network and causes
the segregation of the toughening agent that had been previ-
ously solvated by thermosetting monomer. Thus, curing the
curable composition yields an interpenetrating network that
includes both a brittle thermoset and the toughening agent.
A thermosetting polymeris a polymerwhich becomeshard
or rigid upon curing and which does not become flowable
upon application ofheat, although some softening may occur.
Thermosetting polymersillustratively include epoxyresins,
allyl resins, phenolic resins, polyester resins, melamine-
formaldehydes, polyimides, silicones, multifunctional
acrylic resins, and polyurethane resins. Thermosetting mate-
rial may be provided in the form of a curable flowable ther-
mosetting polymerand/or in the form ofthermosetting mono-
mers and/or oligomers polymerizable to form a thermosetting
polymer. A thermosetting monomeror oligomer included in
an inventive composition may be any of various thermoset-
ting monomersor oligomers polymerizable to yield a ther-
mosetting polymer.
Further components may be included in a curable compos-
ite composition including a lubricant, diluent, hardener, filler,
mold release agent, pigment, colorant, plasticizer, fire retar-
dant, stabilizer, and the like.
The term “curable” as used herein is intended to mean
capable ofundergoing a physical change from a less viscous
state to a more viscous state such as by polymerization,
evaporation of solvent, and particularly, by cross-linking.
Acurable composite composition may be cured by various
methods such as by application of heat or light. Particularly
preferred for use in dental applications is a photocurable
composition. A curing agent, such as an initiator or catalyst,
maybe includedin a curable composition.
In general, the ratio of thermosetting material to toughen-
ing agent in a curable composition is in the range of 10:0.01-
1:1, inclusive. Preferably, the ratio of thermosetting material
to toughening agent in a curable compositionis in the range of
10:0.1-1:0.5, inclusive.
Embodiments of inventive compositions and methods are
illustrated in the following examples. These examples are
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providedforillustrative purposes and are not consideredlimi-
tations on the scope of inventive compositions and methods.
EXAMPLE
Example 1
Synthetic Preparation of Layered Zirconium
Phosphonates by in-situ Templating on Amphiphilic
Liquid Crystals
Step 1
O-Alkylation of Brominated Primary Alcohols (Diem
Method):
To a baffled (indented) 500 mL round-bottom flask, fitted
with an inlet adapter, a condenser, a stopper, and a magnetic
stir bar is added either trimethyloxonium tetrafluoroborate
(10 g, 67 mmol)ortriethyloxonium tetrafluoroborate (10 g,
53 mmol) under passing nitrogen. To the sameflask is also
added either 11-bromo-1l-undecanol (recrystallized from
diethyl ether) or 8-bromo-1-octanol (vacuum distilled) in an
amount no greater than 0.9 molar equivalents of the O-alky-
lating agent. To the same flask is also added either 1,8-bis
(dimethylamino)naphthalene (Proton-Sponge®, Aldrich) or
tribenzylamine (Aldrich) in an amount equal to 1 molar
equivalent of the O-alkylating agent. To the aforementioned
dry powders is added dichloromethane (DCM,ca. 250 mL).
The vessel is sealed under nitrogen backpressure, and the
reactive mixtureis stirred for 1 week at room temperature.
After the reaction, the solid and liquid contents ofthe flask
are separated by vacuum filtration. The isolated DCM solu-
tion is washed one time against a 10% HCIsolution and then
reduced by rotary evaporation. The concentrated, cloudy oil
is then redissolved in diethyl] ether. The filtered cake—com-
prised mostly of organoammoniumtetrafluoroborate salts—
is rinsed with diethyl ether to recover additional product.
Finally, the two ether solutions are recombinedandfiltered to
achieve transparency.
The reaction mixture, now dissolved in diethyl ether, is
washedfirstly against aqueous sodium bicarbonate and sec-
ondly against saturated brine. The solution is then dried
against sodium or magnesium sulfate and filtered. The vola-
tile ether is removed as muchaspossible by rotary evapora-
tion, and the resulting product is tested by small-plate thin-
layer chromatography using diethyl ether as the eluent and
iodine as the developer. TLC results: 11-bromo-1-undecanol,
Rf=0.34; 1-methoxy-11-bromoundecane, Rf=0.69;
1-ethoxy-11-bromoundecane, Rf=0.66. Thelight transparent
oil, 92% pure by H-NMR,is distilled under vacuum, 0.25
mm Hg,over a short path. Yield: 38-61%.
Step 2
Michaelis-Arbruzov Reaction of End-Brominated Alkyl
Ethers:
After purification, 1-methoxy-8-bromooctane, 1-ethoxy-
8-bromooctane, 1-methoxy-11-bromoundecane, and
1-ethoxy-11-bromoundecane,are reacted, respectively, with
triethylphosphite. To a round-bottom flask is added one ofthe
previously purified oils plus about 2 molar equivalents of
freshly distilled triethylphosphite (TEP).In a typical reaction,
about 10 grams of brominated material is reacted together
with about 15 mL ofTEP ina 50 mL round-bottom flask. The
flask was fitted to a short-path distillation apparatus and
heated in an oil bath to reflux, about 160° C., whilestirring
overnight under nitrogen backpressure. The collected ethyl
bromide is removed and TEP is then collected by vacuum
distillation, 0.25 mm Hg,overthe short path. After removing
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TEP from the apparatus, the newly formed ethyl phospho-
ester is isolated in pure form by recovering the second ofthree
fractions from a second vacuum distillation. Yield: 47-87%.
Step 3
Formation of Hydrolyzable Silyl Phosphoesters:
To each of four 25 mL flasks, attached to a four-takeoff
cow-type receiver, is added 37 mmolofone ofthe four phos-
phonates generated in step 2. To a dropping funnel under
nitrogen backpressure is transferred 23 mL oftrimethylsilyl
bromide (Aldrich). Using the dropping funnel, 5.75 mL (41
mmol, 1.1 equivalents) of the silane is added to each of the
phosphoesters while stirring under nitrogen. The reaction is
sealed andleft to stir overnight.
Step 4
Hydrolysis of Silyl Phosphoesters to Phosphonic Acids:
The formed ethyl bromide byproduct and excesssilane are
both pumped away under progressively regulated vacuum.
Each reaction pot is then quenched with 15 mL of 1.5N
NH,OH8,resulting in pH=5-6. The quench is followed by
rinsing with fresh water. Each materialis dissolved in ca. 75
mL DCM and washed against a 5% aqueous HC! solution,
resulting in the formation of a hazy emulsion. Each emulsion
is clarified by the addition of diethylether, facilitating further
separation. Each organic solution is reduced by rotary evapo-
ration, resulting in a white waxysolid. In total, fourwaxes are
isolated, and each is triple-recrystallized from boiling n-hex-
anes. Melt points: methoxyoctylphosphonic acid, 48° C.;
ethoxyoctylphosphonic acid, 50° C.; methoxyundecylphos-
phonic acid, 72° C.; ethoxyundecylphosphonic acid, 69° C.
Step 5
Formation ofAmmonium Salts from Phosphonic Acids:
Equal amounts of each of the four phosphonic acids pre-
pared in steps 1-4 are weighed into a 100 mL round bottom
flask. In a typical experiment, 1 gram ofeach acid is added. To
the flask, containing a mixture of crystalline phosphonic
acids, is added sufficient chloroform to completely dissolve
the acids whilestirring. To the stirred chloroform solution is
added gaseous ammonia by delivery through a cannula. After
15 minutes of continuous bubbling, ammonia delivery is
stopped. The resulting mixture of ammonium phosphonate
salts is dried and weighed, indicating quantitative neutraliza-
tion of the phosphonic acid starting mixture.
Step 6
Formation of a Lamellar Mixture of Ammonium Phospho-
nates:
A quantity of the ammoniated phosphonate mixture from
step 5, e.g. 250 mg,is added to a sealed vessel along with
low-molecular weight polycaprolactone. A small amount,
about 15 weight %, of toluene is added to plasticize the
crystalline polycaprolactone, and a small amount of water,
about 5 weight %, is added to mobilize the phosphonate. The
mixture is heated above the melting point of the polymer,
about 60° C., to form a single dense, lamellar, optically bire-
fringent, mobile phase.
Step 7
Formation of Zircontum Phosphonate Nanoplatelets within
Polymer:
To the mobilized single-phase mixture of ammonium
phosphonates, polycaprolactone, toluene, and water, is added
a warmed saturated solution of zirconyl chloride by rapid
injection. The components are stirred vigorously by vortex
action while still warm and then allowed to cool, yielding a
loose precipitate. Water-solublesalts are rinsed away, and the
remaining material is heated under vacuum,at about 50° C.,
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to allow coalescenceofthe precipitated powder. This results
in the formation of a translucent wax, which could be cooled
and reground for analytical purposes.
Anypatents, publicationsor patent applications mentioned
in this specification are incorporated herein by reference to
the same extent as if each individual publication is specifi-
cally and individually indicated to be incorporated by refer-
ence.
The compositions and methods described herein are pres-
ently representative of preferred embodiments, exemplary,
and not intendedas limitations on the scope ofthe invention.
Changestherein and other uses will occur to those skilled in
the art. Such changes and other uses can be made without
departing from the scope of the invention as set forth in the
claims.
The invention claimedis:
1. A process for producing a layered organo-metal nano-
particle, comprising:
providing a first phase comprising a plurality of liquid
crystal monomers, the liquid crystal monomers each
comprising an organic mesogen anda functional group,
the liquid crystal monomerseach havinga long axis, the
long axis having a first terminus and a second terminus,
wherein the functional group is bondedtothefirst ter-
minus;
providing a second phase comprising a source of metal
ions;
placing a two-phase mixureofthe plurality ofliquid crystal
monomers and the source of metal ions in a reaction
vessel under reaction conditions sufficient to form a
liquid crystal structure comprising the plurality ofliquid
crystal monomers; and
reacting the metal ions and the functional group of the
plurality of liquid crystal monomers to form a bond
between the metal ions and the functional group of the
plurality of liquid crystal monomersyielding a lamellar
organo-metal nanoparticle.
2. The process of claim 1 wherein the source of metal ions
comprises a metal selected from the group consisting of: an
alkaline earth metal, a transition metal and a combination
thereof.
3. The process of claim 2 wherein the transition metalis
selected from the group consisting of: hafnium, tantalum,
tungsten, and a combinationthereof.
4. The process of claim 1 wherein the source of metal ions
comprises zirconium.
5. The process of claim 1 wherein the source of metal ions
is a metalsalt.
6. The process of claim 5 wherein the metalsalt is ZrOC1,.
7. The process of claim 1 wherein the nanoparticle com-
prises a layered zirconium phosphonate.
8. The process ofclaim 1 wherein the functional group is an
oxygen-containing moiety and the bond between the metal
ions and the functional group ofthe plurality of liquid crystal
monomersis a bond between the metal and an oxygen atom of
the oxygen-containing moiety.
9. The process ofclaim 8 whereinthe functional group is an
oxygen-containing moiety selected from the group consisting
of: a phosphate, a phosphonate, a halophosphate, a halophos-
phonate, a dimethylsulfoxide complex of a phosphate, a dim-
ethylsulfoxide complex of a phosphonate, anda salt ofany of
these.
10. The process ofclaim 1 wherein the liquid crystal mono-
merfurther comprises a moiety selected from the group con-
sisting of: a bridging molecule, a miscibility moiety, a reac-
tive group, and a combination thereof.
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11. The process of claim 1 wherein the nanoparticle has a
particle size in the range of 1-1000 nanometers.
12. The process of claim 1 wherein the nanoparticle is a
nanoplatelet.
13. The process of claim 1 wherein the nanoplatelet has a
lateral dimension in the range of 5-1000 nanometers and a
thickness in the range of 5-100 Angstroms.
14. A nanoparticle composition, comprising:
a plurality of organic liquid-crystal monomers boundto a
lamellar metal-containing nanoparticle, wherein the
lamellar metal-containing nanoparticles comprise a
metal selected from the group consisting of: hafnium,
tantalum, tungsten and zirconium.
15. The nanoparticle composition of claim 14 wherein
plurality of organic liquid crystal monomers comprises a
plurality of thermotropic organic liquid crystal monomers.
16. The nanoparticle composition of claim 14 wherein
plurality of organic liquid crystal monomers comprises a
plurality of organic lyotropic liquid crystal monomers.
17.A process for producing a layered organo-metal nano-
particle, comprising:
providing an exfoliated suspension of nanoparticles, the
nanoparticles each having afirst ion exchange group;
providing a plurality ofliquid crystal monomers, the liquid
crystal monomers each comprising an organic mesogen
and a terminal ion exchange group, the liquid crystal
monomers each having a long axis, the long axis having
a first terminus and a second terminus, wherein theter-
minal ion exchangegroupis bondedto thefirst terminus;
mixing the nanoparticle suspension and the plurality of
liquid crystal monomersto create a reaction mixture;
exposing the reaction mixture to ion exchange reaction
conditions such that ion exchange occurs between the
first ion exchange group of the nanoparticles and the
terminal ion exchange groupofthe liquid crystal mono-
mers, creating bonds between the nanoparticles and the
liquid crystal monomers,yielding a lamellar liquid crys-
tal-functionalized nanoparticle.
18. The process of claim 17 whereinthefirst ion exchange
group and the terminal ion exchange group are each selected
from the group consisting of: a phosphate, a phosphonate, a
halophosphate, a halophosphonate, a dimethylsulfoxide
complex of a phosphate, a dimethylsulfoxide complex of a
phosphonate, anda salt of any ofthese.
19. The process of claim 17 wherein the nanoparticle sus-
pension comprises a zirconium phosphonate.
20. The process of claim 17 wherein the nanoplatelet sus-
pension comprises y-ZrPO,(O,P(OH));).
21. The process of claim 17 wherein the liquid crystal
monomerfurther comprises a moiety selected from the group
consisting of: a bridging molecule, a miscibility moiety, a
terminal reactive group, and a combination thereof.
22. A nanocomposite, comprising:
a thermoplastic material; and
a layered organo-metal nanoparticle according to claim 14.
23. A curable composition comprising:
a thermosetting material, and
a nanocomposite according to claim 22.
24. A polymer composite composition, comprising:
an interpenetrating network having a thermosetting poly-
mer component and a toughening agent component, the
toughening agent component comprising a nanocom-
posite according to claim 22.
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